[Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin]
- PMID: 16086876
[Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin]
Abstract
Background & objective: Multidrug resistance is one of the main causes of treatment failure of chemotherapy. Reversal agents may be used to reverse drug-resistance. To date, no appropriate reversal agent is used clinically. This study was to evaluate reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin (DDP), and to explore its mechanisms.
Methods: Lung adenocarcinoma cell line A549 and its DDP-resistant cell line A549/DDP were treated with DDP and H101. Reverse effect of H101 on drug-resistance of A549/DDP to DDP was tested by MTT assay. The levels of cellular multidrug resistant protein 1 (MRP1), glutathione-S-transferase (GST), and topoisomerase-II (TOPO-II) were detected by flow cytometry (FCM). The level of intracellular glutathione (GSH) was measured by fluorescence-Coomassie light blue method. The intracellular concentration of platinum was measured by atomic absorption spectrometry.
Results: The resistance index of A549/DDP cells to DDP was 14.3. After infection of H101, the 50% inhibitory concentration (IC(50)) of DDP to A549/DDP cells reduced from 352.4 micromol/L to 61.6 micromol/L by 5.7 folds. Protein levels of GST and TOPO-II were higher in A549/DDP cells than in A549 cells, which were markedly decreased in A549/DDP cells after infection of H101. No MRP1 protein was detected in both A549 cells and A549/DDP cells. Intracellular amount of GSH in A549/DDP cells was 2 times higher than that in A549 cells, which was significantly decreased after infection of H101. The concentration of platinum in A549 cells was 3 times higher than that in A549/DDP cells. After infection of H101, the concentration of platinum in A549 cells had no significant change, but that in A549/DDP cells was significantly increased.
Conclusion: H101 may reverse drug-resistance of A549/DDP cells to DDP through down-regulating GST and TOPO-IIand increasing intracellular cumulation of platinum.
Similar articles
-
[Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].Zhonghua Yi Xue Za Zhi. 2005 Jun 8;85(21):1493-8. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16061030 Chinese.
-
[Reversal effect of aloe emodin liposomes on cisplatin resistance line A549/DDP human lung adenocarcinoma cells].Zhongguo Zhong Yao Za Zhi. 2008 Jun;33(12):1443-5. Zhongguo Zhong Yao Za Zhi. 2008. PMID: 18837352 Chinese.
-
The role of emodin on cisplatin resistance reversal of lung adenocarcinoma A549/DDP cell.Anticancer Drugs. 2021 Oct 1;32(9):939-949. doi: 10.1097/CAD.0000000000001086. Anticancer Drugs. 2021. PMID: 34001704
-
Role of protein kinases in antitumor drug resistance.Ann Hematol. 1994;69 Suppl 1:S1-6. doi: 10.1007/BF01757347. Ann Hematol. 1994. PMID: 8061107 Review.
-
Cellular accumulation of the anticancer agent cisplatin: a review.Br J Cancer. 1993 Jun;67(6):1171-6. doi: 10.1038/bjc.1993.221. Br J Cancer. 1993. PMID: 8512802 Free PMC article. Review.
Cited by
-
Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors.PLoS One. 2012;7(8):e44301. doi: 10.1371/journal.pone.0044301. Epub 2012 Aug 28. PLoS One. 2012. PMID: 22937170 Free PMC article.
-
Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma.Chin J Cancer. 2011 Dec;30(12):831-41. doi: 10.5732/cjc.011.10301. Epub 2011 Nov 4. Chin J Cancer. 2011. PMID: 22059912 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials